Advanced glycation end-products (AGEs) form when sugar binds proteins, driving aging. This article explains glycation, dietary AGEs, and supplements studied to counter it.
Glycation and AGEs are among the most underappreciated drivers of aging-related tissue damage, yet they rarely make headlines in the supplement space. When blood sugar levels rise, proteins and lipids throughout the body undergo a slow, spontaneous chemical modification that produces compounds called advanced glycation end products (AGEs). These molecules accumulate in skin, blood vessels, kidneys, and even the brain, contributing to stiffness, inflammation, and functional decline over time. Understanding this process is essential for anyone serious about longevity and metabolic health.
What Glycation Actually Is
Glycation is a non-enzymatic reaction between reducing sugars (like glucose and fructose) and free amino groups on proteins, lipids, or nucleic acids. Unlike glycosylation, which is tightly regulated by enzymes for functional purposes, glycation is essentially a chemical accident. It happens continuously, and the rate accelerates whenever blood sugar is elevated.
The initial product is a labile Schiff base, which rearranges into a more stable Amadori product. Over weeks to months, these intermediates undergo further oxidation, dehydration, and cross-linking to form advanced glycation end products (AGEs). Common AGEs include pentosidine, Nε-carboxymethyl-lysine (CML), and Nε-carboxyethyl-lysine (CEL). Once formed, AGEs are largely irreversible under physiological conditions.
Some AGEs form endogenously from circulating glucose. Others enter the body through diet, particularly from foods cooked at high temperatures (grilled meats, fried foods, and baked goods). The relative contribution of dietary versus endogenous AGEs remains debated, but both sources appear to raise circulating AGE levels and promote inflammation.
The Mechanism
AGEs exert damage through two primary pathways. First, they physically alter tissue architecture. Cross-linked collagen in skin and blood vessels becomes stiff and brittle, reducing elasticity and impairing function. This is one reason why diabetes accelerates vascular aging and skin wrinkling.
Second, AGEs activate the receptor for advanced glycation end products (RAGE), a pattern-recognition receptor expressed on macrophages, endothelial cells, and neurons. RAGE engagement triggers downstream signaling through NF-κB, leading to sustained production of pro-inflammatory cytokines (TNF-α, IL-6), oxidative stress, and tissue remodeling. Chronic RAGE activation is implicated in atherosclerosis, diabetic nephropathy, neurodegeneration, and possibly sarcopenia.
Notably, AGE accumulation is not uniform. Tissues with slow protein turnover—such as lens crystallin, tendon collagen, and basement membrane collagen—accumulate AGEs most dramatically. This explains why cataracts, vascular stiffness, and kidney damage are common complications of prolonged hyperglycemia.
The NAD+ Connection
One underexplored angle is the relationship between glycation and NAD+ metabolism. NAD+ is a central coenzyme for sirtuins, PARPs, and hundreds of other enzymes. NAD+ levels decline with age, and this decline has been linked to impaired mitochondrial function, DNA repair, and metabolic flexibility. Gomes et al. (2013) demonstrated that declining NAD+ disrupts nuclear-mitochondrial communication, creating a pseudohypoxic state that accelerates aging phenotypes in mice.
Why does this matter for glycation? NAD+-dependent enzymes like sirtuins (SIRT1, SIRT3) help regulate glucose homeostasis, insulin sensitivity, and inflammatory responses. When NAD+ is depleted, these protective pathways weaken, potentially allowing glycation stress to proceed unchecked. Restoring NAD+ levels through precursor supplementation—specifically with nicotinamide mononucleotide (NMN)—has emerged as a strategy to support metabolic resilience, though the direct impact on AGE formation in humans remains unstudied.
The Evidence Base
Human data on interventions that reduce AGE burden is limited. Most clinical trials have focused on diabetes management rather than AGE-lowering per se. Metformin, caloric restriction, and low-AGE diets have all shown modest effects on circulating AGE markers in small studies, but none have been tested in large, long-term RCTs for anti-aging outcomes.
Where the evidence is stronger is in the NAD+ precursor literature. NMN supplementation has been shown to raise NAD+ levels and improve metabolic parameters in humans, which may indirectly support defenses against glycation-related stress. Yoshino et al. (2021) conducted a randomized, placebo-controlled trial in prediabetic women and found that NMN (250 mg/day) increased muscle insulin sensitivity and upregulated genes involved in muscle remodeling. Improved insulin sensitivity means tighter postprandial glucose control, which should theoretically reduce glycation flux.
Igarashi et al. (2022) extended this work to healthy older men, showing that 250 mg/day NMN for 12 weeks elevated blood NAD+ levels and improved muscle function, including gait speed and grip strength. Irie et al. (2020) confirmed dose-dependent NAD+ metabolite increases in healthy Japanese men at doses ranging from 100 to 500 mg/day, with no adverse effects reported. Liao et al. (2021) found that NMN at 600–1200 mg/day enhanced aerobic capacity in amateur runners, suggesting benefits extend to active populations.
Niu et al. (2023) reported that short-term NMN supplementation altered serum metabolism, shifted fecal microbiota composition, and was associated with telomere length changes in a pre-aging cohort. While none of these studies measured AGEs directly, the consistent theme is that NMN improves metabolic and cellular parameters that sit upstream of glycation stress.
| Study | Population | NMN Dose | Duration | Key Outcome | Direct AGE Measurement? |
|---|---|---|---|---|---|
| Yoshino et al. (2021) | Prediabetic women | 250 mg/day | 10 weeks | ↑ Muscle insulin sensitivity | No |
| Igarashi et al. (2022) | Healthy older men | 250 mg/day | 12 weeks | ↑ NAD+, ↑ Muscle function | No |
| Irie et al. (2020) | Healthy Japanese men | 100–500 mg/day | Single dose to 12 weeks | ↑ NAD+ metabolites (dose-dependent) | No |
| Liao et al. (2021) | Amateur runners | 600–1200 mg/day | 6 weeks | ↑ Aerobic capacity (VO2) | No |
| Niu et al. (2023) | Pre-aging adults | 300 mg/day | 8 weeks | ↑ Telomere length, metabolic shifts | No |
The table above makes one fact clear: NMN human trials have not yet incorporated AGE endpoints. Any claim that NMN directly lowers AGEs in humans would be speculative. What the data do support is that NMN improves insulin sensitivity and NAD+ status, which are plausibly linked to reduced glycation pressure.
Who Benefits Most
The populations with the strongest rationale for addressing glycation and AGEs are those with existing metabolic dysfunction. Individuals with prediabetes, type 2 diabetes, or insulin resistance experience chronically elevated blood glucose, which accelerates AGE formation. For these groups, glycation is not an abstract concern—it is an active contributor to vascular complications, nephropathy, and accelerated aging.
Older adults represent another high-priority group. AGE accumulation is cumulative and partially irreversible; by age 60, skin autofluorescence (a proxy for tissue AGE load) is substantially higher than at age 30. Combined with the natural decline in NAD+ described by Gomes et al. (2013), older adults face a dual burden: more AGEs and fewer metabolic defenses. NMN supplementation may help restore some of this NAD+-dependent capacity, though expectations should remain modest pending direct outcome data.
Athletes and physically active individuals may also benefit from glycation awareness. High-intensity exercise generates transient oxidative stress and glucose fluctuations. While exercise is overwhelmingly net-positive for metabolic health, understanding how to support recovery and tissue maintenance—including through NAD+ precursors—fits within an evidence-based optimization framework. Liao et al. (2021) showed that NMN improved aerobic capacity in runners, which suggests a potential role for NMN in supporting athletic metabolic health, though again, AGE-specific data are absent.
What the Evidence Does Not Show
It is important to be clear about the boundaries of current knowledge. No human RCT has demonstrated that lowering AGEs through diet or supplements extends lifespan or prevents specific diseases. Animal studies (mostly in rodents) show that restricting dietary AGEs or administering AGE inhibitors like aminoguanidine improves renal and vascular outcomes, but translation to humans is uncertain.
Similarly, no published human trial has measured whether NMN supplementation reduces skin AGEs, vascular stiffness, or inflammatory markers directly attributable to RAGE activation. The mechanistic link between NAD+ and glycation is biologically plausible but remains theoretical in human populations. Anyone marketing NMN as an "AGE blocker" is overstating the evidence.
Finally, dietary AGE reduction strategies remain controversial. Cooking methods that minimize AGE formation (poaching, steaming, boiling) also reduce food palatability and may lower nutrient bioavailability in some cases. The practical trade-offs are real, and the optimal balance has not been established in controlled trials. For guidance on evaluating supplement claims and bioavailability, see our guides on How to Read Supplement Labels and Bioavailability Explained.
Practical Takeaways
- Keep fasting glucose and HbA1c in the healthy range. Tight glycemic control is the single most effective way to reduce endogenous AGE formation.
- Consider cooking methods that use lower temperatures and more moisture (steaming, stewing, poaching) to limit dietary AGE intake, without becoming overly restrictive.
- NMN supplementation may support metabolic resilience through NAD+ restoration. Human data show improved insulin sensitivity and muscle function at doses of 250–500 mg/day. For those exploring NAD+ precursors, Bio:sudo NMN 1000mg provides a dose that aligns with the upper ranges studied in athletic populations.
- Do not expect supplements to reverse established AGE cross-links. Once formed, most AGEs are permanent; prevention is the only viable strategy.
- Combine any supplementation strategy with resistance training and adequate protein intake. Muscle tissue is a major site of glucose disposal, and maintaining muscle mass is protective against glycation stress.
- If you are new to supplementation, our Supplement Beginner Guide covers how to build a coherent, evidence-based stack without falling for hype.
Bottom Line
Glycation and AGEs are real biochemical processes that contribute to tissue aging, particularly in the context of hyperglycemia and insulin resistance. The evidence for direct AGE-lowering interventions in humans remains limited. NAD+ precursor supplementation with NMN shows promise for improving metabolic parameters that sit upstream of glycation, but no human trial has yet connected NMN to reduced AGE formation. The most defensible approach today is glycemic control first, with NMN as a potential adjunct for metabolic support rather than a standalone anti-glycation therapy.
References
- Yoshino M, et al. "Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women." Science. 2021;372(6547):1224–1229. [Source]
- Igarashi M, et al. "Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men." npj Aging. 2022;8(1):5. [Source]
- Irie J, et al. "Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men." Endocrine Journal. 2020;67(2):153–160. [Source]
- Liao B, et al. "Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study." Journal of the International Society of Sports Nutrition. 2021;18(1):54. [Source]
- Gomes AP, et al. "Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging." Cell. 2013;155(7):1624–1638. [Source]
- Niu KM, et al. "The impacts of short-term NMN supplementation on serum metabolism, fecal microbiota, and telomere length in pre-aging phase." Nutrients. 2023;15(3):755. [Source]